FDA rejected Merck & Co. Inc.’s criticism about the value of its proposed study of the use of animated characters in direct-to-consumer (DTC) advertising, saying the findings could help the agency develop guidance and policy.
In March, FDA announced plans for the “Animation in Direct-to-Consumer-Advertising” study, to be conducted by the Office of Prescription Drug Promotion. (Also see "DTC Safety Messages Could Vary By Platform As FDA Considers Screen Size" - Pink Sheet, 8 March, 2016.)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?